Search

Your search keyword '"DIMULESCU, DOINA"' showing total 39 results

Search Constraints

Start Over You searched for: Author "DIMULESCU, DOINA" Remove constraint Author: "DIMULESCU, DOINA"
39 results on '"DIMULESCU, DOINA"'

Search Results

1. Contemporary Management of Severe Symptomatic Aortic Stenosis

2. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

3. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

4. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

5. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

6. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

8. Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial

9. Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism

10. Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism

12. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

15. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

16. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

18. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

19. Augmented Survival, Angiogenic Properties and Mobilization of Human Endothelial Progenitor Cells Following Exposure to Sevoflurane

21. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

22. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

23. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

24. Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients

25. Dysfunctional HDL characterized by decreased paraoxonase 1 and increased apolipoproteins AII, CIII and myeloperoxidase levels discriminate between acute coronary syndrome and stable CAD patients

27. Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages

28. MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients

31. AN UNEXPECTED COMPLICATION OF APPENDICITIS.

33. Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C.

35. An observational, prospective study of the pharmacoinvasive strategy approach to ST-segment myocardial infarction (STEMI) in the era of primary percutaneous coronary intervention based on Elias Heart Centre Interventional Registry (EIRE Study). The Southern Romanian experience

36. Hypertension and acute coronary syndromes in Romania: data from the ISACS-TC registry

37. THYROID HORMONES AND PROINFLAMMATORY CYTOKINES' PROFILE IN AMIODARONE-INDUCED THYROTOXICOSIS.

38. TRI-IODOTHYRONINE AS A RISK FACTOR FOR ATRIAL FIBRILLATION IN AMIODARONE-INDUCED HYPERTHYROIDISM.

39. Pregătirea de bază a rezidenţilor în cardiologie: Recomandările Societăţii Române de Cardiologie.

Catalog

Books, media, physical & digital resources